Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of Loss to Follow-up Among HIV-infected Patients in a Rural South-Eastern Nigeria Hospital: A 5-year Retrospective Cohort Study.

Annals of medical and health sciences research·2016
Same author

Mesenteric lipoma causing recurrent intestinal obstruction.

Nigerian journal of clinical practice·2013
Same author

Sacrohysteropexy with synthetic mesh in Aba, South-Eastern Nigeria: a report of three cases and review of the literature.

Nigerian journal of clinical practice·2013
Same author

Symphysiotomy- a dying art: the experience at Federal Medical Centre Umuahia Nigeria.

The Nigerian postgraduate medical journal·2011
Same author

Awareness, acceptability, and use of male condoms for contraception and prevention of sexually transmitted infection among female students in a tertiary institution in South Eastern Nigeria.

Nigerian journal of clinical practice·2007
Same author

Placenta accreta in Aba, south eastern, Nigeria.

Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria·2007

Related Experiment Video

Updated: May 13, 2026

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

Placenta accreta and the developing world--a review.

C C Umezurike1, P A Feyi-Waboso

  • 1Department of Obstetrics and Gynaecology, Nigerian Christian Hospital, P. M. B. 823 Aba, Abia State, Nigeria.

East African Medical Journal
|March 6, 2013
PubMed
Summary

The rising rate of placenta accreta, linked to increased Cesarean sections, poses a significant maternal health risk globally. Early detection and careful management are crucial for reducing complications and mortality.

More Related Videos

Ex Vivo Placental Explant Flow Culture - Mimicking the Dynamic Conditions In Utero
04:17

Ex Vivo Placental Explant Flow Culture - Mimicking the Dynamic Conditions In Utero

Published on: September 8, 2023

Human Placental and Decidual Organ Cultures to Study Infections at the Maternal-fetal Interface
07:04

Human Placental and Decidual Organ Cultures to Study Infections at the Maternal-fetal Interface

Published on: July 21, 2016

Related Experiment Videos

Last Updated: May 13, 2026

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

Ex Vivo Placental Explant Flow Culture - Mimicking the Dynamic Conditions In Utero
04:17

Ex Vivo Placental Explant Flow Culture - Mimicking the Dynamic Conditions In Utero

Published on: September 8, 2023

Human Placental and Decidual Organ Cultures to Study Infections at the Maternal-fetal Interface
07:04

Human Placental and Decidual Organ Cultures to Study Infections at the Maternal-fetal Interface

Published on: July 21, 2016

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Public Health

Background:

  • Increasing Cesarean section rates globally suggest a potential rise in placenta accreta incidence.
  • Placenta accreta is a serious obstetric complication that can significantly increase maternal morbidity and mortality.

Purpose of the Study:

  • To alert obstetricians and healthcare professionals to the growing challenge of placenta accreta.
  • To highlight the need for increased awareness and preparedness for placenta accreta cases.

Main Methods:

  • Comprehensive literature review including original research and reviews.
  • Searches of electronic databases such as Medline, Pubmed, and Embase.
  • Inclusion of information from textbooks and electronic resources.

Main Results:

  • Data synthesized from various sources to categorize relevant information.
  • Identification of key aspects related to placenta accreta management.

Conclusions:

  • Optimal management involves recognizing risk factors, accurate antenatal diagnosis, and meticulous delivery planning.
  • A high index of suspicion and advanced preparation are essential, especially in developing countries lacking reliable diagnostic methods.
  • Effective strategies are needed to mitigate the rising maternal morbidity and mortality associated with placenta accreta.